secwatch / observer
8-K filed May 2, 2025, 7:59 PM ET ticker VBIO CIK 0001787740
other material confidence high sentiment neutral materiality 0.75

Tivic Health enters up to $8.4M Series B Preferred financing with Helena Global

Valion Bio, Inc.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Valion Bio, Inc.: Filed Certificate of Designation for Series B Non-Voting Convertible Preferred Stock, designating new series of preferred stock with specific rights and preferences (effective 2025-04-29).

Change
charter amendment
Effective
2025-04-29
Exact text from the filing
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On April 29, 2025, the Company filed a Certificate of Designation of Preferences, Rights and Limitations of the Series B Non-Voting Convertible Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware in connection with the Offering discussed above in Item 1.01.
View on SEC.gov

13 governance changes filed in the last 30 days. Browse all governance changes →

Valion Bio, Inc. filing history →

Source: SEC EDGAR
accession 0000950170-25-062733
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.